This federal contract award, valued at $5,839.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive distribution capabilities and medical product expertise make it a key vendor for federal healthcare programs, particularly within the Department of Defense and Veterans Affairs systems.
Generated 1/22/25, 1:01 AM